As you’ll know, the CiteAb team are all very passionate about validation (don’t miss our next Antibody Validation meeting planned for September 2018!), making this award one that is possibly our favourite.

We’re thrilled to see Thermo Fisher Scientific take the crown for 2018 for the company’s 2-part Validation Approach.

This approach is a 2-part testing approach, validating the company’s most widely used antibodies for specificity and utility in different applications. These include secondaries as well as the company’s eBioscience flow cytometry antibodies.

What’s exciting about this approach is the comprehensive nature of the testing methods. Not only is the company testing for application, and providing data on its website showing which applications each antibody works best in, but they also test for specificity as well and posts that data on product pages. Thermo’s 2-part testing approach uses one of 9 specificity tests, including; IP-mass spectrometry, Knock out, Knock down, Independent antibody verification, Cell treatment, Relative Expression, Neutralization, Peptide array and Orthogonal method. By employing a variety of specificity testing methods, the company can ensure that it employs the appropriate validation test based on the use and function of a specific antibody.

Once an antibody has been tested using this 2-part approach, it receives a ‘badge’ on the company’s website called the advanced verification badge. This badge provides customers with further confidence of its performance and use in their experiments.

Dr Andrew Chalmers, Founder of CiteAb, said: “Our judges for this category were impressed by the thoroughness of Thermo Fisher Scientific using so many methods to address specificity, but also of its novelty, making it easy to understand for customers and therefore easy to navigate to validated reagents on the company’s website.”

View past winners